Patents by Inventor Jing-Song Tao

Jing-Song Tao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of inflammatory diseases including psoriasis
    Patent number: 7863429
    Abstract: Inhibitors of integrin-linked kinase (ILK) are used in the treatment of inflammatory disease, including cutaneous inflammatory diseases, such as psoriasis, scleroderma, systemic lupus erythematosus and atopic dermatitis.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: January 4, 2011
    Assignees: QLT Inc., Sunnybrook and Women's College and Health Science Centre
    Inventors: Shoukat Dedhar, Greg Hannigan, David W. C. Hunt, Jing-Song Tao, Ladan Fazli
  • Compositions for Treatment of Diseases of the Nail Unit
    Publication number: 20080299165
    Abstract: A flowable composition suitable for use as a controlled release implant, the composition comprising a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid; a biocompatible polar aprotic solvent selected from the group consisting of an amide, an ester, a carbonate, a ketone, an ether, and a sulfonyl; wherein the biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid, and antifungal active.
    Type: Application
    Filed: February 17, 2006
    Publication date: December 4, 2008
    Inventors: Jing-song Tao, Ronald Erwin Boch, Alain H. Curaudeau, Peter Lutwyche, Agnes How-Ching Chan
  • Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins
    Publication number: 20080096857
    Abstract: The present method involves the photodynamic treatment of hyperactive gland disorders. The method involves the topical administration of a photosensitizer composition comprising hydrophobic and/or lipophilic green porphyrins such as lemuteporfin, polyethylene glycol and skin penetration enhancers such as oleyl alcohol and TRANSCUTOL™ to affected skin and subsequent exposure of that skin to energy of a wavelength capable of activating the photosensitizer.
    Type: Application
    Filed: February 8, 2005
    Publication date: April 24, 2008
    Applicant: QLT Inc.
    Inventors: Alain H. Curaudeau, Herma C. Neyndorff, Jing-Song Tao, Julia G. Levy, David W.C. Hunt, Morgan Chun Lam, Patrick Mark Curry, Valery Rubinchik
  • Treatment of neovascular opthalmic disease
    Publication number: 20050074455
    Abstract: Inhibitors of integrin-linked kinase (ILK) are used in the treatment of various eye diseases with underlining pathology of neovascularization of cornea, iris, retina or choroid.
    Type: Application
    Filed: November 29, 2002
    Publication date: April 7, 2005
    Inventors: Philipe Margaron, Jing-Song Tao
  • Treatment of inflammatory diseases including psoriasis
    Publication number: 20020155179
    Abstract: Inhibitors of integrin-linked kinase (ILK) are used in the treatment of inflammatory disease, including cutaneous inflammatory diseases, such as psoriasis, scleroderma, systemic lupus erythematosus and atopic dermatitis.
    Type: Application
    Filed: November 30, 2001
    Publication date: October 24, 2002
    Inventors: Shoukat Dedhar, Greg Hannigan, David W.C. Hunt, Jing-Song Tao, Ladan Fazli